Company research
Pear Therapeutics, Inc.
CIK 1835567Updated Sep 24, 2026
Securities
Historical securities (10)
PEAR · OTC · equity · closed Apr 18, 2023THMA · OTC · equity · closed Dec 6, 2021TMAC · NASDAQ · equity · closed Dec 2, 2022PEARQ · NASDAQ · equity · closed May 22, 2024PEARW · NYSE_AMERICAN · warrant · closed Apr 18, 2023PERWQ · NASDAQ · warrant · closed Apr 11, 2024THMAU · NASDAQ · unit · closed Dec 3, 2021TMAC.WS · NYSE · warrant · closed Dec 2, 2022THMAW · NASDAQ · warrant · closed Dec 3, 2021TMAC.UN · NYSE · unit · closed Dec 2, 2022Name history
Thimble Point Acquisition Corp. · through Dec 3, 2021
PEAR price & chart
Historical security
This listing closed Apr 18, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 95,129,000Source | 197,160,000Source | 132,366,000Source |
| Property, Plant and Equipment, NetUSD | 6,076,000Source | 6,255,000Source | 4,277,000Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 48,301,000Source | 169,567,000Source | 110,900,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,943,000Source | 1,794,000Source | 257,000Source |
| Assets, CurrentUSD | 72,959,000Source | 185,241,000Source | 126,057,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 6,675,000Source | 8,876,000Source | 1,365,000Source |
| Operating Lease, Right-of-Use AssetUSD | 8,879,000Source | — | — |
| Other Assets, NoncurrentUSD | 6,804,000Source | 5,253,000Source | 871,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 64,544,000Source | 106,726,000Source | 45,250,000Source |
| Stockholders’ equity: | |||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 14,000Source | 14,000Source | 11,000Source |
| Additional Paid in CapitalUSD | 354,092,000Source | 338,404,000Source | 269,946,000Source |
| Retained Earnings (Accumulated Deficit)USD | -323,474,000Source | -247,983,000Source | -182,841,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -47,000Source | -1,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | 30,585,000Source | 90,434,000Source | 87,116,000Source |
| Liabilities and EquityUSD | 95,129,000Source | 197,160,000Source | 132,366,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 49,442,000Source | 47,166,000Source | 40,686,000Source |
| Operating Lease, Liability, CurrentUSD | 1,984,000Source | — | — |
| Accounts Payable, CurrentUSD | 3,263,000Source | 1,806,000Source | 4,506,000Source |
| Operating Lease, Liability, NoncurrentUSD | 8,176,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 541,000Source | 1,994,000Source | 1,239,000Source |
| Additional Financial Items | |||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 59,272,000Source | 174,571,000Source | — |
| Long-term Debt, Excluding Current Maturities | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 27,447,000Source | 26,993,000Source | 26,345,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 0Source | 0Source | — |
| Short-term InvestmentsUSD | 10,971,000Source | 5,004,000Source | 13,535,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 13,533,000Source | 3,810,000Source | 9,026,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | 5,150,000Source | 1,192,000Source | -751,000Source |
| Increase (Decrease) in Accounts PayableUSD | 4,000Source | -3,094,000Source | 1,730,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -113,895,000Source | -109,043,000Source | -67,894,000Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -9,457,000Source | 2,883,000Source | 58,925,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,470,000Source | 3,278,000Source | 3,900,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 2,155,000Source | 164,077,000Source | 91,703,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -121,197,000Source | 57,917,000Source | 82,734,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 48,781,000Source | 169,978,000Source | 112,061,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,560,000Source | 3,709,000Source | 2,039,000Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 13,533,000Source | 3,810,000Source | 9,026,000Source |
| Amortization of Intangible AssetsUSD | 620,000Source | 563,000Source | 50,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 59,272,000Source | 174,571,000Source | — |
| DepreciationUSD | 3,347,000Source | 1,689,000Source | 381,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | 0Source | -998,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 2,879,000Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -75,491,000Source | -65,142,000Source | -97,023,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -75,491,000Source | -65,142,000Source | -108,076,000Source |
| Operating Lease, ExpenseUSD | 2,878,000Source | — | — |
| Other Nonoperating Income (Expense)USD | 47,859,000Source | 40,543,000Source | -20,379,000Source |
| Payments of Financing CostsUSD | — | 0Source | 1,500,000Source |
| Proceeds from Issuance of Common StockUSD | — | 63,870,000Source | — |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 60,048,000Source | 16,525,000Source | 79,600,000Source |
| Proceeds from Stock Options ExercisedUSD | 1,795,000Source | 859,000Source | 409,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Total RevenueUSD | 12,694,000Source | 4,208,000Source | 9,384,000Source |
| Cost of Goods and Services Sold | — | — | — |
| Gross Profit (Calculated) · Derived | — | — | — |
| Selling, General and Administrative ExpenseUSD | 79,551,000Source | 67,619,000Source | 56,226,000Source |
| Operating Income (Loss)USD | -123,350,000Source | -105,685,000Source | -76,644,000Source |
| Other Nonoperating Income (Expense)USD | 47,859,000Source | 40,543,000Source | -20,379,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -75,491,000Source | -65,142,000Source | -97,023,000Source |
| Earnings Per Share, BasicUSD per share | -0.54Source | -0.57Source | -1.21Source |
| Earnings Per Share, DilutedUSD per share | -0.54Source | -0.57Source | -1.21Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 138,707,278Source | 113,328,450Source | 89,216,091Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 138,707,278Source | 113,328,450Source | 89,216,091Source |
| Additional Financial Items | |||
| Amortization of Intangible AssetsUSD | 620,000Source | 563,000Source | 50,000Source |
| Costs and ExpensesUSD | 136,044,000Source | 109,893,000Source | 86,028,000Source |
| Interest Income (Expense), NetUSD | -3,892,000Source | -4,144,000Source | -1,767,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -75,491,000Source | -65,142,000Source | -108,076,000Source |
| Operating Lease, ExpenseUSD | 2,878,000Source | — | — |
| Research and Development ExpenseUSD | 48,311,000Source | 37,041,000Source | 28,084,000Source |